A cell-based assay revealed that the SPC25 can be a potential biomarker for Alzheimer’s disease as the expression level of SPC25 was significantly upregulated in the serum samples of patients with mild cognitive impairment (Zhang et al., 2018). This evidence concerns the gene SPC25 and Alzheimer disease.